Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Bronchodilators Market to reach USD 50.67 billion by the end of 2029.

Global Bronchodilators Market Size study & Forecast, by Indication (Asthma, Chronic obstructive pulmonary disease (COPD), Others), by Drug Type (Sympathomimetics, Anticholinergics, Phosphodiesterase Inhibitor, Combination Drugs), by Route Of Administration (Oral, Injection, Inhaler) and Regional Analysis, 2022-2029

Product Code: HLSDT-10565794
Publish Date: 17-04-2023
Page: 200

Global Bronchodilators Market is valued at approximately USD 33.78 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2029. A bronchodilator is a type of drug that relaxes the muscles in the lungs (bronchi) airway passageways and widens them to make breathing easier. They enhance airflow within the lungs and lessen resistance in the respiratory tract. Additionally, bronchodilators are utilized to lessen pulmonary mucus. These medications are taken by patients with respiratory conditions using inhalers or nebulizers. Inhalation bronchodilators additionally influence mucociliary clearance. By relaxing the muscles in the lungs and enlarging the airways, bronchodilators are employed in the treatment of obstructive lung disorders (bronchi). The growing awareness regarding the treatment of lung diseases, increasing geriatric population, coupled with the rise in number of smokers are the primary factors that are fostering the market demand across the globe.

The rising prevalence of lung diseases is acting as a chief driving factor for the growth of the global market. For instance, the World Health Organization (WHO) lists respiratory disease infections as the third leading cause of mortality, accounting for around 3 million deaths per year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, it is estimated that 262 million people worldwide have asthma, which typically affects youngsters. Thus, the high incidences of various respiratory and lung diseases are augmenting the market demand at a substantial rate. Moreover, the heightened pollution levels globally, as well as the growing R&D investments related to bronchodilators are presenting various lucrative opportunities over the forecasting years. However, the adverse effects of bronchodilators and long approval times and stringent regulations are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bronchodilators Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness regarding the treatment of COPD, asthma, and other chronic respiratory disorders, along with the rising number of government initiatives. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of respiratory disorder patient pool, improving healthcare infrastructure, and rise in demand for bronchodilators in the pharmaceutical sector across the regional market.

Major market players included in this report are:
Abbott Laboratories
AstraZeneca plc.
Boehringer Ingelheim International GmbH
GlaxoSmithKline Plc.
F. Hoffmann-La Roche Ltd.
Novartis AG.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Vectura Group Plc

Recent Developments in the Market:
Ø In May 2020, Glenmark Pharmaceuticals Ltd. declared that the company has successfully launched its Single Inhaler Triple Therapy (AIRZ-FF) which is a combination of two bronchodilators, namely, Formoterol and Glycopyrronium, and corticosteroid Fluticasone propionate. The product is specially designed for Chronic Obstructive Pulmonary Disease (COPD) patients in India.
Ø In October 2020, Zydus Cadila announced that the company received final approval from the United States Food and Drug Administration (USFDA) to trade its Albuterol Tablets (in the strengths of 2 mg and 4 mg) which are used to treat and prevent bronchospasm.

Global Bronchodilators Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Indication, Drug Type, Route Of Administration, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:
Chronic obstructive pulmonary disease (COPD)

By Drug Type:
Phosphodiesterase Inhibitor
Combination Drugs
By Route Of Administration:

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Bronchodilators Market, by Region, 2019-2029 (USD Billion)
1.2.2. Bronchodilators Market, by Indication, 2019-2029 (USD Billion)
1.2.3. Bronchodilators Market, by Drug Type, 2019-2029 (USD Billion)
1.2.4. Bronchodilators Market, by Route Of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bronchodilators Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bronchodilators Market Dynamics
3.1. Bronchodilators Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Increase in number of smokers Rising prevalence of lung diseases
3.1.2. Market Challenges Adverse effects of bronchodilators Long approval times and stringent regulations
3.1.3. Market Opportunities Heightened pollution levels globally Growing R&D investments related to bronchodilators
Chapter 4. Global Bronchodilators Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Bronchodilators Market, by Indication
6.1. Market Snapshot
6.2. Global Bronchodilators Market by Indication, Performance – Potential Analysis
6.3. Global Bronchodilators Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Bronchodilators Market, Sub Segment Analysis
6.4.1. Asthma
6.4.2. Chronic obstructive pulmonary disease (COPD)
6.4.3. Others
Chapter 7. Global Bronchodilators Market, by Drug Type
7.1. Market Snapshot
7.2. Global Bronchodilators Market by Drug Type, Performance – Potential Analysis
7.3. Global Bronchodilators Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
7.4. Bronchodilators Market, Sub Segment Analysis
7.4.1. Sympathomimetics
7.4.2. Anticholinergics
7.4.3. Phosphodiesterase Inhibitor
7.4.4. Combination Drugs
Chapter 8. Global Bronchodilators Market, by Route Of Administration
8.1. Market Snapshot
8.2. Global Bronchodilators Market by Route Of Administration, Performance – Potential Analysis
8.3. Global Bronchodilators Market Estimates & Forecasts by Route Of Administration 2019-2029 (USD Billion)
8.4. Bronchodilators Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injection
8.4.3. Inhaler
Chapter 9. Global Bronchodilators Market, Regional Analysis
9.1. Bronchodilators Market, Regional Market Snapshot
9.2. North America Bronchodilators Market
9.2.1. U.S. Bronchodilators Market Indication breakdown estimates & forecasts, 2019-2029 Drug Type breakdown estimates & forecasts, 2019-2029 Route Of Administration breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Bronchodilators Market
9.3. Europe Bronchodilators Market Snapshot
9.3.1. U.K. Bronchodilators Market
9.3.2. Germany Bronchodilators Market
9.3.3. France Bronchodilators Market
9.3.4. Spain Bronchodilators Market
9.3.5. Italy Bronchodilators Market
9.3.6. Rest of Europe Bronchodilators Market
9.4. Asia-Pacific Bronchodilators Market Snapshot
9.4.1. China Bronchodilators Market
9.4.2. India Bronchodilators Market
9.4.3. Japan Bronchodilators Market
9.4.4. Australia Bronchodilators Market
9.4.5. South Korea Bronchodilators Market
9.4.6. Rest of Asia Pacific Bronchodilators Market
9.5. Latin America Bronchodilators Market Snapshot
9.5.1. Brazil Bronchodilators Market
9.5.2. Mexico Bronchodilators Market
9.5.3. Rest of Latin America Bronchodilators Market
9.6. Rest of The World Bronchodilators Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.2.2. AstraZeneca plc.
10.2.3. Boehringer Ingelheim International GmbH
10.2.4. GlaxoSmithKline Plc.
10.2.5. F. Hoffmann-La Roche Ltd.
10.2.6. Novartis AG.
10.2.7. Pfizer Inc.
10.2.8. SANOFI
10.2.9. Teva Pharmaceutical Industries Ltd.
10.2.10. Vectura Group Plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now